Nazea injection 0.3mg contains ramosetron hydrochloride, a 5-HT3 receptor antagonist, used to prevent and treat nausea and vomiting caused by chemotherapy or surgery, and also to treat irritable bowel syndrome (IBS) with predominant diarrhea. This injectable drug, manufactured by LTL Pharma, has a YJ code of 2391403A1025 and comes in a 0.3mg 2mL 1 tube standard.
Nazea injection 0.3mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
